Transit employers that receive Federal Transit Administration assistance must run an anti-drug and alcohol misuse program that satisfies 49 CFR Part 655 and the testing procedures in 49 CFR Part 40. If you manage compliance, your first move is to confirm which employees and contractors fall under the rule, adopt or update a written policy that references the current FTA random testing minimums, and verify that your lab, Medical Review Officer, and consortium all meet DOT and HHS standards.

TL;DR:

  • The minimum random drug testing rate will increase to 50%, and alcohol testing remains at 10%, effective January 15, 2026, requiring policy updates.
  • All recipients, subrecipients, and safety-sensitive contractors of FTA funds must maintain a compliant drug and alcohol testing program, regardless of company size or specific role.
  • Oral fluid testing requires validation through two HHS-certified labs; until then, urine remains the default specimen type for DOT-regulated testing.
  • Testing procedures must follow strict chain-of-custody rules, with results reviewed by an MRO, and records kept for at least five years for positive results.
  • Agency policies should reference the published minimum testing rates directly, include contractor oversight provisions, and ensure collection coverage during off-hours to avoid common compliance gaps.
Total Tox
Keep Transit Testing Compliance Moving
Total Tox provides expedited DOT testing, MRO-reviewed results, and audit-ready documentation for transit employers and safety-sensitive contractors.
Visit Total Tox

Table of Contents

Who has to follow FTA drug testing rules?

Part 655 covers recipients and subrecipients of FTA formula, capital, or rural assistance funds, along with any contractor performing a safety-sensitive function on their behalf. That reach is broader than many agencies assume. Even an informal or ongoing arrangement that hands someone safety-sensitive duties, like vehicle operation or maintenance, can pull that person’s employer into the program, according to FTA guidance on shared mobility arrangements.

A few applicability points come up constantly during audits:

  • A direct recipient and every subrecipient of FTA funds must each maintain a compliant program, not just the lead agency.
  • Contractors who dispatch or operate vehicles, maintain revenue vehicles, or control dispatch functions are typically covered, regardless of company size.
  • Taxicab service is generally excluded from Part 655 unless it operates under a public transit contract with safety-sensitive functions assigned.
  • Agencies running both FTA-funded transit and FMCSA-regulated commercial operations need separate, correctly labeled testing pools for each program.

What does a compliant Part 655 program require?

Part 655 Subpart B lays out specific program elements, and each one should show up as a distinct section in your written policy, not buried in general language.

  1. A written policy statement describing prohibited conduct, consequences, and which positions are safety-sensitive.
  2. A testing program that follows Part 40 collection, laboratory, and reporting procedures exactly.
  3. Education and training materials distributed to employees and supervisors before testing begins.
  4. Substance Abuse Professional referral procedures triggered automatically by a verified positive or refusal.
  5. Notice requirements that document when and how employees received the policy, typically through signed acknowledgment forms.
  6. Immediate removal from safety-sensitive duty following a verified positive, refusal to test, or alcohol concentration at or above the regulatory threshold.

These elements come directly from §655.11 through §655.17, and an FTA audit will typically request your written policy alongside proof of distribution and training.

Pro Tip: Keep a signed acknowledgment on file for every covered employee the day they start, not retroactively after a testing event raises questions.

When do pre-employment, random, and post-accident tests apply?

Each test type has its own trigger, and mixing them up is one of the most common findings in agency reviews.

  • Pre-employment testing happens before a candidate performs any safety-sensitive function, with a verified negative required before they start.
  • Random testing draws unannounced selections throughout the year using a scientifically valid method, with no advance notice to the employee.
  • Reasonable suspicion testing requires a trained supervisor to document specific, contemporaneous observations before ordering the test.
  • Post-accident testing applies after qualifying accidents meeting FTA’s fatality, injury, or disabling-damage thresholds, and must happen as soon as possible.
  • Return-to-duty and follow-up testing apply after a Substance Abuse Professional evaluation, with follow-up testing continuing for a minimum period the SAP sets, typically at least one year with no fixed cap beyond five years.

A verified positive or refusal triggers immediate removal from safety-sensitive duty, mandatory MRO confirmation of the result, and a SAP referral before any return-to-duty process can begin.

What are the current FTA random testing rates?

The FTA minimum random drug testing rate is 50% and the minimum random alcohol testing rate is 10%, effective January 15, 2026, according to the FTA’s notice on random testing rates. These are floors, not targets: agencies that already test above the minimum can keep their existing rate without any policy change.

Several practical points follow from how FTA publishes these numbers:

  • Writing “FTA annual minimum random testing rates as published” into your policy avoids a manual rewrite every time the Administrator issues a new notice.
  • Lowering a rate that currently exceeds the minimum is optional, and should be documented as a deliberate decision with a dated policy revision.
  • If you selected employees earlier in the year at a lower rate, you can either retain those selections and simply under-sample for the remainder of the testing period, or re-select the pool at the new rate.
  • Either approach needs a documented rationale and timestamp, since auditors will ask how you reconciled a rate change mid-cycle, a point FTA’s Part 655 Questions and Answers addresses directly.

Which specimen types can you use, and what does oral fluid testing require?

DOT authorizes oral fluid as an alternate specimen type to urine, but employers cannot actually implement oral fluid collections until HHS certifies at least two laboratories, one for primary testing and one for split-specimen testing. That certification condition, described in the DOT/ODAPC May 2023 notice, means agencies should confirm current lab certification status before switching methods rather than assuming oral fluid is fully available everywhere.

Specimen type Authorized use Key condition
Urine Primary method for all DOT test types Standard chain-of-custody form required
Oral fluid Alternate method Requires two HHS-certified labs before full implementation
Hair Not authorized for DOT-regulated testing N/A under Part 40

Where oral fluid labs aren’t yet certified for a given test, Part 40’s directly observed collection and temporary urine fallback provisions apply, as outlined in the 2025 Federal Register notice. Authorized testing panels and cutoff levels for both urine and oral fluid come from the HHS Mandatory Guidelines, which remain the controlling reference regardless of which specimen type a lab processes. Our comparison of hair follicle and urine testing covers detection-window differences in more depth, and Mayflower Bioscience’s breakdown of urine versus saliva testing is a useful technical reference on detection windows across specimen types.

How should collections and MRO reviews actually run?

Part 40 governs the mechanics: a qualified collector, the Custody and Control Form or Alcohol Testing Form, and a documented chain of custody for every sample. A Medical Review Officer reviews every non-negative lab result before it’s reported to the employer, and employees have the right to request split-specimen testing if they dispute a verified positive.

A few operational rules trip agencies up repeatedly:

  • Instant or rapid testing devices are never permitted for DOT-regulated tests; every specimen must go to an HHS-certified lab, a point DOT’s employer FAQ page states plainly.
  • DOT and non-DOT testing processes must stay completely separate, using different forms and never sharing a single chain of custody.
  • Direct observation is required in specific circumstances, such as a return-to-duty test or a previous specimen that showed signs of tampering.
  • Collection sites need to be available across every shift your safety-sensitive employees work, including nights and weekends, or you need a pre-arranged alternate site.

Pro Tip: Confirm your consortium or third-party administrator’s after-hours collection coverage in writing before you need it for a post-accident test at 2 a.m.

How long do you need to keep testing records?

FTA expects documentation that proves your program ran as written, not just that a policy exists on paper.

  1. Keep verified positive, refusal, and alcohol-violation records for a minimum of five years.
  2. Retain negative test results and the required annual summary reports for at least two years.
  3. Keep education and training records, including signed acknowledgments, for the duration of employment plus at least two years.
  4. Build contractor language into every service agreement that specifies which employees are covered, how random pools are combined or kept separate, and who holds responsibility for MRO review.
  5. Conduct an internal check at least annually comparing your actual testing numbers against your policy’s stated rates, so a gap surfaces before an FTA reviewer finds it.

Contractor oversight deserves special attention since the agency, not the contractor, typically answers to FTA for gaps in coverage.

How should you handle confidentiality during testing?

Every step of a drug and alcohol test touches sensitive medical information, and Part 40 builds confidentiality protections directly into the collection and reporting process. Collectors can only discuss a specimen’s chain of custody, never its contents, and only the Medical Review Officer has the clinical context needed to interpret a non-negative result before it reaches your desk as a simple positive or negative determination.

Test results, medical records, and SAP evaluation details belong in files separate from an employee’s general personnel record, with access limited to the people who have a legitimate operational need, typically a designated employer representative and the MRO. Collection sites also need enough physical privacy for a legitimate specimen collection without crossing into procedures that would constitute an unauthorized observed collection, which Part 40 permits only under specific triggered circumstances like a return-to-duty test.

Separate confidential testing records and access paths

Agencies that outsource collections to a clinic or mobile service should confirm in writing how that provider stores records, who can access results, and how long data stays on file after a contract ends. A breach of confidentiality, even an accidental one, like a supervisor mentioning a result in an unrelated meeting, can undermine the legal defensibility of an otherwise properly conducted test. Training supervisors on what they’re allowed to know (a positive or negative determination and fitness for duty) versus what they’re not allowed to ask about (specific substances or treatment details) closes one of the more common gaps agencies run into during a real-world incident review.

What has changed recently in FTA testing rules?

The most consequential recent update is the random testing rate itself: the minimum random drug testing rate rose to 50% and the alcohol rate held at 10%, effective January 15, 2026, per FTA’s published notice. Any agency that built its policy around a fixed percentage rather than a reference to the published minimum needs to revise that language now.

On the specimen side, HHS continues working through laboratory certification for oral fluid testing, and the March 2026 Federal Register update reaffirms the authorized testing panels and cutoffs that apply once that certification clears. Until enough labs hold certification for both primary and split-specimen oral fluid testing, urine remains the practical default for most agencies, with directly observed collection serving as the fallback where DOT guidance requires it. Agencies should check certification status periodically rather than assuming oral fluid has become fully available.

Where transit compliance programs go wrong in practice

The recurring failure point we see isn’t ignorance of the rules, it’s policy language that hardcodes a fixed percentage instead of referencing the FTA minimum as published, which forces an avoidable rewrite every time the Administrator issues a new notice. Contractor oversight is the second weak spot: agencies assume a vendor’s safety-sensitive staff are automatically covered without ever confirming it in the contract. The third is collection coverage during off-hours, when a post-accident or reasonable suspicion test can’t wait for a clinic to open. Building a contractual audit clause and a pre-arranged alternate collection site into your program before you need either one closes most of the gaps we encounter.

— Total Tox

How Total Tox supports transit agency compliance

We provide walk-in, same-day DOT drug and alcohol collections designed to support transit compliance officers. Our clinic offers urine collections for DOT-regulated test types, with results reviewed by an MRO and documentation prepared for audit purposes.

Total Tox

When you’re evaluating any testing provider for your program, check four things: HHS lab certification status, MRO review practices, turnaround time, and whether the paperwork you get back is audit-ready without extra formatting on your end. Our DOT-compliant testing services are built around exactly those four points, with typical results delivered within 24 hours.

  • Same-day, walk-in collections designed to minimize downtime for safety-sensitive employees.
  • MRO-reviewed results and documentation formatted for regulatory recordkeeping.
  • DOT physicals, urine collections, and hair testing services available for agencies managing multiple program requirements.

If your agency needs a reliable collection site for random, post-accident, or return-to-duty testing, reach out to schedule a service agreement with our Bronx clinic.

FAQ

What is an FTA drug test?

An FTA drug test is a DOT-regulated urine (or, where available, oral fluid) test required under 49 CFR Part 655 for transit employees in safety-sensitive positions. It follows Part 40 collection and laboratory procedures and requires Medical Review Officer confirmation before any result is reported to the employer.

What are the requirements for a drug test under FTA rules?

A compliant FTA drug test requires an HHS-certified laboratory, a qualified collector following Part 40 chain-of-custody procedures, and MRO review of any non-negative result before it’s verified. Agencies also need a written policy, employee notice, and documented SAP referral procedures as required under Part 655.

What is the policy for federal employees regarding drug testing?

Federal transit employees in safety-sensitive roles are subject to the same Part 655 and Part 40 framework as other covered transit workers, including pre-employment, random, reasonable suspicion, post-accident, and return-to-duty testing. Their employing agency must maintain a written policy referencing current FTA random testing minimums and document employee notification.

How long do you have to be without drugs to pass a drug test?

Detection windows vary by substance and specimen type, so there’s no single universal timeframe that applies to every drug test. Urine and oral fluid tests follow the panels and cutoffs set in the HHS Mandatory Guidelines, and detection periods differ enough between substances that a compliance officer shouldn’t rely on general assumptions when advising employees.

Sources